NasdaqCM - Delayed Quote USD
NeuroSense Therapeutics Ltd. (NRSN)
1.0000
+0.0246
+(2.52%)
At close: 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-10,135
-10,135
-8,354
-7,616
-1,539
Investing Cash Flow
1
1
3,468
-3,590
-17
Financing Cash Flow
10,913
10,913
3,975
3,774
11,902
End Cash Position
3,378
3,378
2,640
3,543
11,063
Capital Expenditure
-3
-3
-29
-70
-17
Issuance of Capital Stock
11,304
11,304
4,334
--
9,864
Repayment of Debt
--
--
-80
-79
--
Free Cash Flow
-10,138
-10,138
-8,383
-7,686
-1,556
12/31/2021 - 12/9/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NLSP NLS Pharmaceutics AG
1.5000
+1.35%
COYA Coya Therapeutics, Inc.
6.53
-0.46%
SCNI Scinai Immunotherapeutics Ltd.
2.4200
-2.81%
RVPHW Reviva Pharmaceuticals Holdings, Inc.
0.0700
+10.24%
VAXX Vaxxinity, Inc.
0.0155
+7,650.01%
LSB LakeShore Biopharma Co., Ltd
1.3300
0.00%
AMLX Amylyx Pharmaceuticals, Inc.
5.24
+3.56%
KPRX Kiora Pharmaceuticals, Inc.
3.2000
+1.27%
AVIR Atea Pharmaceuticals, Inc.
2.8700
+0.70%
IMAB I-Mab
0.8523
-1.03%